This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Albemarle (ALB) Scales New 52-Week High on Bright Prospects
by Zacks Equity Research
Albemarle (ALB) scaled a fresh 52-week high of $112.82 on May 15.
Albemarle (ALB) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Albemarle Corporation (ALB) recorded earnings of $51.2 million or 45 cents per share for the first quarter of 2017 compared with $228.2 million or $2.02 a year ago.
Will Univar (UNVR) Spring a Surprise this Earnings Season?
by Zacks Equity Research
Univar Inc. (UNVR) is slated to release first-quarter 2017 results ahead of the bell on May 5.
Should You Buy Albemarle (ALB) Ahead of Earnings?
by Zacks Equity Research
Albemarle (ALB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Delphi Automotive (DLPH) Q1 Earnings: Another Beat in Store?
by Zacks Equity Research
Delphi Automotive PLC (DLPH) is set to report first-quarter 2017 results on May 3.
Will Tesla's (TSLA) Q1 Earnings Beat on Higher Unit Sales?
by Zacks Equity Research
Tesla, Inc. (TSLA) is set to report first-quarter 2017 results after the market closes on May 3.
Albemarle (ALB) Q1 Earnings Preview: A Beat in the Cards?
by Zacks Equity Research
Albemarle (ALB) will release its first-quarter 2017 results after the bell on May 3.
Eastman Chemical (EMN) Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Eastman Chemical (EMN) is set to release first-quarter 2017 results after the bell on Apr 27.
Dow Chemical (DOW) Q1: Can it Sustain the Earnings Streak?
by Zacks Equity Research
Dow Chemical (DOW) is scheduled to report its first-quarter 2017 results ahead of the bell on Apr 27.
U.S. Steel (X) Q1 Earnings Preview: Stock Poised to Beat?
by Zacks Equity Research
U.S. Steel (X) is set to release its first-quarter 2017 results after the bell on Apr 25.
DuPont (DD) Q1 Earnings: Can the Stock Spring a Surprise?
by Zacks Equity Research
DuPont (DD) is gearing up to release its first-quarter 2017 results ahead of the bell on Apr 25.
Arconic (ARNC) Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Arconic (ARNC) is slated to release its first-quarter 2017 results after the close on Apr 25.
Newmont (NEM) to Report Q1 Earnings: A Beat in the Cards?
by Zacks Equity Research
Newmont (NEM) is scheduled to report first-quarter 2017 results after the closing bell on Apr 24.
WestRock (WRK) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
WestRock Company (WRK), a provider of paper and packaging solutions, is set to report second-quarter fiscal 2017 results on Apr 26.
Freeport (FCX) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Freeport-McMoRan Inc. (FCX) is set to release first-quarter 2017 results ahead of the bell on Apr 25.
Allegheny (ATI) to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Allegheny Technologies Incorporated (ATI) is scheduled to release first-quarter 2017 results before the market opens on Apr 25.
6 Reasons to Add Albemarle (ALB) Stock to Your Portfolio
by Zacks Equity Research
Strong fundamentals and compelling growth prospects make Albemarle an attractive choice for investment.
Monsanto's (MON) Prospects Look Bright on Solid Q2 Earnings
by Zacks Equity Research
On Apr 10, we issued an updated research report on premium agricultural chemicals firm, Monsanto Company (MON).
Cosan Limited's (CZZ) Growth Potential Solid: Time to Buy?
by Zacks Equity Research
We issued an updated research report on Cosan Limited (CZZ) on Apr 5, 2017.
Monsanto (MON) Tops Q2 Earnings, Updates FY17 EPS Outlook
by Zacks Equity Research
Monsanto Company (MON) reported better-than-expected second-quarter fiscal 2017 (ended Feb 28, 2017) results.
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Albemarle, Syngenta and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Albemarle, Syngenta and Monsanto
Air Products to Discuss Latest LNG Technology Innovations
by Zacks Equity Research
Air Products (APD) has announced plans to demonstrate the latest innovations in liquefied natural gas (LNG) technology at the Gastech Conference & Exhibition in Tokyo through Apr 4???7.
Why Monsanto (MON) is a Must-Add Stock to Your Portfolio?
by Zacks Equity Research
Monsanto Company (MON) is a must-add to your portfolio now.
Vale S.A. (VALE) Downgraded to Hold on Industry Headwinds
by Zacks Equity Research
On Mar 27, Zacks Investment Research downgraded Vale S.A. (VALE) to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
Albemarle to Double Lithium Production at Greenbushes Mine
by Zacks Equity Research
The Greenbushes project is a key part of Albemarle's (ALB) lithium expansion plans geared at addressing the growing needs of its customers.